Skip to main content

UPDATE 2-Moderna extends lipids deal to boost COVID-19 vaccine candidate output

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine as the U.S. biotech looks to build capacity and produce enough doses to meet expected global demand.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.